rawfin.tv
CapsoVision Expects Q3 FDA Clearance for AI Highlights, Q4 CapsoCam Colon Submission
TechnologystocksAI Generated

CapsoVision Expects Q3 FDA Clearance for AI Highlights, Q4 CapsoCam Colon Submission

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

CapsoVision anticipates receiving FDA clearance for its AI Highlights product by the end of the third quarter. The company also aims to submit its CapsoCam Colon device for regulatory approval in the fourth quarter.

CapsoVisionFDA ApprovalMedical DevicesAIHealthcare

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks